There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
A recombinant humanized anti-IgE mAb, omalizumab, forms complexes with free IgE, blocking
its interaction with mast cells and basophils; as a consequence, it might be effective
in the treatment of asthma.